Policy and Regulation
ACA Marketplace Premiums Could Rise 20% in 2026
Healthcare policy analysts are projecting potentially significant premium increases of up to 20% for Affordable Care Act (ACA) marketplace plans in 2026, driven by a
Healthcare policy analysts are projecting potentially significant premium increases of up to 20% for Affordable Care Act (ACA) marketplace plans in 2026, driven by a
The FDA has granted clearance to Nyxoah’s innovative Genio system, a breakthrough hypoglossal nerve stimulation device designed to treat obstructive sleep apnea. This regulatory approval
HeartFlow has made a spectacular public market debut, with shares soaring 47% following the company’s $317 million initial public offering on Nasdaq. The strong market
Pfizer and BioNTech have reached a substantial $740 million settlement agreement with CureVac to resolve a complex patent dispute involving foundational mRNA technology that underpins
The FDA has imposed significant restrictions on Bluebird Bio’s Skysona gene therapy following the emergence of concerning cancer risks in treated patients. This regulatory action
The FDA has granted approval to Hernexeos, a breakthrough targeted therapy for advanced lung cancer, marking a significant milestone in oncology treatment options for patients